a public good project by the
Synthesis
Company
of California

© 2026

Corine van Marrewijk | doi.page

0 works0 citations0 h-index

Corine van Marrewijk

Radboud University Nijmegen(NL)Radboud University Medical Center(NL)Radboud Institute for Molecular Life Sciences(NL)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders, Aortic aneurysm repair treatments, Acute Lymphoblastic Leukemia research, Cardiac, Anesthesia and Surgical Outcomes

Most-Cited Works

→ Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: The EUROSTAR experience(2000)751 cited
→ Significance of endoleaks after endovascular repair of abdominal aortic aneurysms: The EUROSTAR experience(2002)485 cited
→ Diameter of abdominal aortic aneurysm and outcome of endovascular aneurysm repair: does size matter? A report from EUROSTAR(2004)280 cited
→ The significance and management of different types of endoleaks(2003)133 cited
→ Emergency treatment of acute symptomatic or ruptured abdominal aortic aneurysm. Outcome of a prospective intent-to-treat by EVAR protocol(2003)118 cited
→ Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study(2018)101 cited

→ Life expectancy after endovascular versus open abdominal aortic aneurysm repair: Results of a decision analysis model on the basis of data from EUROSTAR(2002)74 cited

→ Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes(2019)67 cited

→ Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry(2019)56 cited

→ Causes and outcomes of open conversion and aneurysm rupture after endovascular abdominal aortic aneurysm repair: can type ii endoleaks be dangerous?11No competing interests declared.(2002)49 cited